vimarsana.com
  1. Home
  2. Live Updates
  3. Early Feasibility Clinical Study - Breaking News

Latest Breaking News On - Early feasibility clinical study - Page 1 : vimarsana.com

Hart to Heart: SCV native leads company s breakthrough in heart valve tech for kids

Hart to Heart: SCV native leads company s breakthrough in heart valve tech for kids
signalscv.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from signalscv.com Daily Mail and Mail on Sunday newspapers.

United statesCarnegie mellon universityDoug bernsteinSanta claritaDrug administrationHart high schoolHumanitarian use deviceInvestigational device exemptionEarly feasibility clinical study

PECA Labs Achieves Successful First-In-Human Implant of the MASA Valve Pediatric Pulmonary Valved Conduit in U S Clinical Trial

Novel polymeric valve aims to reduce re-operations and re-interventions

United statesDoug bernsteinDavid moralesDrug administrationHeart institute at cincinnati children hospitalHumanitarian use deviceInvestigational device exemptionEarly feasibility clinical studyHeart instituteCincinnati children

Vivani Medical (VANI) Wins $1M NIH Grant Funding to Support Cortigent s Ongoing Orion Clinical Study

Vivani Medical (VANI) Wins $1M NIH Grant Funding to Support Cortigent s Ongoing Orion Clinical Study
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Los angelesUnited statesSean leousDon dwyerCompany contactCompany annual report on formDrug administrationNeuromodulation divisionCompany or vivaniSecond sight medical products incUniversity of californiaCortigent incNational institutes of healthVivani medical incNational institutesEarly feasibility clinical study

Vivani Medical Announces $1 Million NIH Grant Funding to Support Cortigent s Ongoing Orion Clinical Study

Vivani Medical, Inc. , an emerging biopharmaceutical company which develops miniaturized, subdermal implants today announced that the Company received notice from the National Institutes of Health . | April 4, 2023

Los angelesUnited statesVivani medical incNational institutes of healthSecond sight medical products incNeuromodulation divisionCompany or vivaniUniversity of californiaCortigent incVivani medicalNational institutesEarly feasibility clinical studyOrion visual cortical prosthesisSecond sight medical productsOrion early feasibility studySecond sight

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.